Synopsys revenue and financials
In the fiscal year ended October 2025, Synopsys reported revenue of $7.05B (+15.12% year over year). Net income was $1.33B, a net margin of 18.9%.
Fiscal year ending in October. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +15.12%
- FY to Oct 2025 vs FY to Oct 2024
- Net income growth
- −41.14%
- FY to Oct 2025 vs FY to Oct 2024
- Net margin
- 18.9%
- FY to Oct 2024: 36.9%
How Synopsys is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 13.9% a year on average over the last 5 years
Compound annual growth rate: from $3.69B in 2020 to $7.05B in 2025.
Revenue has grown for 9 fiscal years in a row
Each fiscal year compared with the one before, up to 2025.
Operating margin fell from 22.6% to 13.0%
Operating income over revenue, 2022 → 2025: 9.6 percentage points.
Free cash flow equal to 86% of net income
Totals for fiscal years 2023–2025: free cash flow $4.13B, net income $4.83B.
Shares outstanding up 6.4% in 5 years
Average diluted shares, 2020 → 2025: with more shares, each one represents a smaller stake in the company (dilution).
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | FY to Oct 2025 | FY to Oct 2024 | FY to Oct 2023 | FY to Oct 2022 | FY to Oct 2021 | FY to Oct 2020 | FY to Oct 2019 | FY to Oct 2018 | FY to Oct 2017 | FY to Oct 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7,054 | 6,127 | 5,318 | 5,082 | 4,204 | 3,685 | 3,361 | 3,121 | 2,725 | 2,423 |
| Cost of revenue | 1,624 | 1,245 | 1,031 | 898 | 862 | 795 | 753 | 736 | 654 | 543 |
| Gross profit | 5,431 | 4,882 | 4,287 | 3,718 | 3,342 | 2,891 | 2,608 | 2,385 | 2,071 | 1,880 |
| Selling, general and administrative | 1,844 | 1,428 | 1,102 | 956 | 1,035 | 917 | 862 | 860 | 738 | 668 |
| Research and development | 2,479 | 2,082 | 1,850 | 1,590 | 1,505 | 1,279 | 1,137 | 1,085 | 909 | 857 |
| Operating income | 915 | 1,356 | 1,273 | 1,149 | 735 | 620 | 520 | 360 | 348 | 317 |
| EBIT | 915 | 1,409 | 1,326 | 1,160 | 768 | 656 | 567 | 399 | 392 | 327 |
| EBITDA | 1,328 | 1,599 | 1,526 | 1,343 | 922 | 815 | 710 | 526 | 511 | 445 |
| Interest expense | 447 | 36.8 | 1.2 | 1.7 | 3.4 | 5.1 | 11.7 | 15.6 | 7.3 | 3.8 |
| Pre-tax income | 1,393 | 1,514 | 1,305 | 1,103 | 806 | 638 | 546 | 364 | 383 | 330 |
| Income tax | 56.0 | 99.7 | 90.2 | 139 | 49.2 | -25.3 | 13.1 | -69.0 | 247 | 62.7 |
| Net income | 1,332 | 2,263 | 1,230 | 985 | 758 | 664 | 532 | 433 | 137 | 267 |
| Net income to common shareholders | 1,332 | 2,263 | 1,230 | 985 | 758 | 664 | 532 | 433 | 137 | 267 |
| Basic EPS | 8.13 | 14.78 | 8.08 | 6.44 | 4.96 | 4.40 | 3.55 | 2.90 | 0.91 | 1.76 |
| Diluted EPS | 8.04 | 14.51 | 7.92 | 6.29 | 4.81 | 4.27 | 3.45 | 2.82 | 0.88 | 1.73 |
| Average shares (basic) | 164 | 153 | 152 | 153 | 153 | 151 | 150 | 149 | 150 | 152 |
| Average shares (diluted) | 166 | 156 | 155 | 156 | 157 | 156 | 154 | 153 | 155 | 155 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q to Jul 2026 | Q to Apr 2026 | Q to Jan 2026 | Q to Oct 2025 | Q to Jul 2025 | Q to Apr 2025 | Q to Jan 2025 | Q to Oct 2024 | Q to Jul 2024 | Q to Apr 2024 | Q to Jan 2024 | Q to Oct 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2,477 | 2,276 | 2,409 | 2,255 | 1,740 | 1,604 | 1,455 | 1,636 | 1,526 | 1,455 | 1,511 | 1,467 |
| Cost of revenue | 432 | 381 | 389 | 405 | 334 | 311 | 261 | 308 | 276 | 287 | 266 | 274 |
| Gross profit | 2,045 | 1,894 | 2,020 | 1,849 | 1,406 | 1,294 | 1,194 | 1,328 | 1,250 | 1,168 | 1,245 | 1,194 |
| Selling, general and administrative | 563 | 554 | 579 | 576 | 540 | 352 | 376 | 391 | 362 | 325 | 350 | 289 |
| Research and development | 720 | 700 | 715 | 747 | 625 | 554 | 553 | 555 | 509 | 493 | 526 | 466 |
| Operating income | 360 | 236 | 321 | 121 | 165 | 376 | 252 | 364 | 360 | 332 | 353 | 423 |
| EBIT | 360 | 236 | 321 | 121 | 165 | 376 | 252 | 364 | 360 | 332 | 353 | 423 |
| EBITDA | 622 | 499 | 578 | 376 | 242 | 418 | 292 | 413 | 403 | 391 | 392 | 475 |
| Interest expense | 133 | 133 | 163 | 195 | 147 | 94.3 | 11.1 | 16.3 | 11.7 | 7.1 | 1.3 | 0.3 |
| Pre-tax income | 684 | 19.3 | 79.1 | 517 | 189 | 396 | 291 | 323 | 392 | 342 | 457 | 404 |
| Income tax | 138 | 2.4 | 14.3 | 68.1 | -53.0 | 47.2 | -6.3 | 62.1 | -30.7 | 45.4 | 22.9 | 60.4 |
| Net income | 546 | 17.1 | 65.0 | 449 | 243 | 345 | 296 | 1,114 | 408 | 292 | 449 | 349 |
| Net income to common shareholders | 546 | 17.1 | 65.0 | 449 | 243 | 345 | 296 | 1,114 | 408 | 292 | 449 | 349 |
| Basic EPS | 2.85 | 0.09 | 0.34 | 2.42 | 1.51 | 2.23 | 1.91 | 7.24 | 2.66 | 1.91 | 2.95 | 2.30 |
| Diluted EPS | 2.84 | 0.09 | 0.34 | 2.40 | 1.50 | 2.22 | 1.89 | 7.15 | 2.62 | 1.88 | 2.90 | 2.26 |
| Average shares (basic) | 192 | 191 | 190 | 186 | 160 | 155 | 154 | 154 | 153 | 153 | 152 | 152 |
| Average shares (diluted) | 192 | 192 | 191 | 188 | 162 | 156 | 156 | 156 | 156 | 156 | 155 | 155 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | FY to Oct 2025 | FY to Oct 2024 | FY to Oct 2023 | FY to Oct 2022 | FY to Oct 2021 | FY to Oct 2020 | FY to Oct 2019 | FY to Oct 2018 | FY to Oct 2017 | FY to Oct 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 48,224 | 13,074 | 10,333 | 9,418 | 8,752 | 8,030 | 6,405 | 6,146 | 5,396 | 5,240 |
| Current assets | 6,012 | 6,470 | 3,431 | 3,013 | 2,808 | 2,549 | 1,739 | 1,544 | 1,683 | 1,717 |
| Cash and equivalents | 2,888 | 3,897 | 1,439 | 1,418 | 1,433 | 1,236 | 729 | 723 | 1,048 | 977 |
| Short-term investments | 72.9 | 154 | 152 | 148 | 148 | — | — | — | — | 141 |
| Receivables | 2,391 | 1,692 | 1,233 | 1,057 | 853 | 1,028 | 789 | 631 | 499 | 495 |
| Inventory | 365 | 362 | 326 | 212 | 229 | 192 | 142 | 122 | 61.9 | — |
| Net property, plant and equipment | 1,399 | 1,129 | 1,110 | 1,042 | 966 | 950 | 430 | 309 | 266 | 257 |
| Goodwill | 26,899 | 3,449 | 4,070 | 3,121 | 3,576 | 3,365 | 3,171 | 3,143 | 2,707 | 2,518 |
| Other intangible assets | 12,680 | 195 | 240 | 386 | 279 | 254 | 279 | 360 | 254 | 267 |
| Long-term investments | — | — | — | 31.9 | 17.6 | 13.2 | 11.0 | 10.9 | 7.8 | 9.8 |
| Current liabilities | 3,722 | 2,650 | 2,985 | 2,774 | 2,413 | 2,140 | 1,752 | 2,102 | 1,614 | 1,715 |
| Accounts payable | 165 | 207 | 155 | 37.6 | 27.4 | 30.0 | 19.8 | 85.0 | 20.0 | 13.7 |
| Long-term debt | 13,485 | 15.6 | 18.1 | 20.8 | 25.1 | 101 | 120 | 126 | 134 | — |
| Total debt | 14,293 | 684 | 678 | 656 | 667 | 663 | 138 | 139 | 144 | — |
| Total liabilities | 19,897 | 4,050 | 4,149 | 3,859 | 3,453 | 3,118 | 2,316 | 2,661 | 2,117 | 2,045 |
| Total equity (incl. minority) | 28,327 | 9,023 | 6,184 | 5,559 | 5,299 | 4,912 | 4,089 | 3,485 | 3,280 | 3,195 |
| Retained earnings | 10,315 | 8,984 | 6,742 | 5,534 | 4,550 | 3,795 | 3,164 | 2,544 | 2,144 | 1,948 |
| Minority interest | -0.6 | 32.5 | 37.0 | 43.5 | 3.8 | 5.0 | 5.9 | 5.9 | 4.1 | — |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q to Jul 2026 | Q to Apr 2026 | Q to Jan 2026 | Q to Oct 2025 | Q to Jul 2025 | Q to Apr 2025 | Q to Jan 2025 | Q to Oct 2024 | Q to Jul 2024 | Q to Apr 2024 | Q to Jan 2024 | Q to Oct 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 47,726 | 46,889 | 47,238 | 48,224 | 48,230 | 23,757 | 13,041 | 13,074 | 11,649 | 11,012 | 10,558 | 10,333 |
| Current assets | 6,644 | 5,437 | 5,374 | 6,012 | 5,596 | 16,879 | 6,324 | 6,470 | 5,128 | 4,653 | 3,408 | 3,431 |
| Cash and equivalents | 3,606 | 2,412 | 2,130 | 2,888 | 2,526 | 14,119 | 3,654 | 3,897 | 1,840 | 1,503 | 1,119 | 1,434 |
| Short-term investments | 1.4 | 72.0 | 73.9 | 72.9 | 67.2 | 145 | 155 | 154 | 154 | 157 | 154 | 152 |
| Receivables | 2,185 | 1,296 | 2,416 | 2,391 | 2,214 | 1,900 | 1,723 | 1,692 | 1,499 | 1,366 | 1,533 | 1,233 |
| Inventory | 479 | 442 | 393 | 365 | 382 | 395 | 415 | 362 | 386 | 378 | 383 | 326 |
| Net property, plant and equipment | 1,444 | 1,412 | 1,390 | 1,399 | 1,393 | 1,158 | 1,092 | 1,129 | 1,128 | 1,095 | 1,118 | 1,110 |
| Goodwill | 26,835 | 26,854 | 26,881 | 26,899 | 26,946 | 3,461 | 3,433 | 3,449 | 3,444 | 3,427 | 4,131 | 3,346 |
| Other intangible assets | 11,459 | 11,875 | 12,290 | 12,680 | 13,080 | 173 | 181 | 195 | 266 | 277 | 377 | 240 |
| Long-term investments | 0.7 | 0.5 | 0.9 | — | — | — | — | — | — | — | — | — |
| Current liabilities | 4,970 | 3,791 | 3,943 | 3,722 | 3,444 | 2,406 | 2,359 | 2,650 | 2,535 | 2,508 | 2,645 | 2,985 |
| Accounts payable | 187 | 179 | 113 | 165 | 133 | 84.7 | 102 | 207 | 78.5 | 92.3 | 76.8 | 155 |
| Long-term debt | 9,017 | 10,014 | 10,022 | 13,462 | 14,318 | 10,028 | 14.2 | 15.6 | 15.6 | 17.0 | 17.0 | 18.1 |
| Total debt | 10,842 | 10,842 | 10,869 | 14,293 | 15,140 | 10,742 | 665 | 684 | 674 | 645 | — | — |
| Total liabilities | 16,575 | 16,412 | 16,690 | 19,897 | 20,616 | 13,841 | 3,736 | 4,050 | 3,903 | 3,823 | 3,852 | 4,149 |
| Total equity (incl. minority) | 31,151 | 30,477 | 30,548 | 28,327 | 27,614 | 9,916 | 9,305 | 9,023 | 7,745 | 7,189 | 6,707 | 6,184 |
| Retained earnings | 10,943 | 10,398 | 10,380 | 10,315 | 9,867 | 9,624 | 9,279 | 8,984 | 7,884 | 7,478 | 7,189 | 6,742 |
| Minority interest | -1.2 | -1.1 | -0.8 | -0.6 | -0.3 | -0.1 | 0.1 | 32.5 | 36.0 | 35.7 | 35.6 | 37.0 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | FY to Oct 2025 | FY to Oct 2024 | FY to Oct 2023 | FY to Oct 2022 | FY to Oct 2021 | FY to Oct 2020 | FY to Oct 2019 | FY to Oct 2018 | FY to Oct 2017 | FY to Oct 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1,519 | 1,407 | 1,703 | 1,739 | 1,493 | 991 | 801 | 424 | 632 | 587 |
| Depreciation and amortization | 660 | 295 | 247 | 228 | 204 | 210 | 202 | 209 | 189 | 207 |
| Capital expenditure | -169 | -140 | -190 | -137 | -93.8 | -155 | -198 | -99.0 | -70.3 | -66.9 |
| Investing cash flow | -15,881 | 1,223 | -482 | -573 | -549 | -360 | -236 | -744 | -189 | -143 |
| Financing cash flow | 13,356 | -181 | -1,197 | -1,116 | -749 | -141 | -562 | 5.1 | -373 | -307 |
| Share repurchases | 0.0 | 0.0 | -1,161 | -1,100 | -753 | -242 | -329 | -400 | -380 | -400 |
| Debt issued | 14,329 | 0.0 | 0.0 | 0.0 | — | 276 | 193 | 621 | 320 | 185 |
| Debt repaid | -864 | -74.9 | -2.6 | -76.8 | -28.1 | -289 | -524 | -295 | -381 | -185 |
| Effect of exchange rates | 1.9 | 8.8 | -3.0 | -65.3 | 2.4 | 17.2 | 2.8 | -11.1 | -0.4 | 3.4 |
| Net change in cash | -1,005 | 2,458 | 21.3 | -15.3 | 197 | 507 | 5.5 | -325 | 69.7 | 140 |
| Free cash flow | 1,349 | 1,268 | 1,514 | 1,602 | 1,399 | — | — | — | — | — |
| Levered free cash flow | 2,171 | 800 | 1,265 | 1,550 | 1,301 | 769 | 351 | 455 | 524 | 476 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q to Jul 2026 | Q to Apr 2026 | Q to Jan 2026 | Q to Oct 2025 | Q to Jul 2025 | Q to Apr 2025 | Q to Jan 2025 | Q to Oct 2024 | Q to Jul 2024 | Q to Apr 2024 | Q to Jan 2024 | Q to Oct 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 813 | 629 | 857 | 640 | 671 | 275 | -67.5 | 563 | 455 | 477 | -87.8 | 326 |
| Depreciation and amortization | 262 | 263 | 257 | 255 | 77.1 | 41.6 | 39.7 | 48.5 | 42.8 | 59.2 | 39.8 | 52.5 |
| Capital expenditure | -66.6 | -54.2 | -35.3 | -34.5 | -38.6 | -55.6 | -40.7 | -20.7 | -40.0 | -38.4 | -40.4 | -53.1 |
| Investing cash flow | 443 | -52.9 | -36.5 | 564 | -16,500 | 76.0 | -22.0 | 1,443 | -53.8 | -112 | -54.4 | -301 |
| Financing cash flow | -37.8 | -281 | -1,583 | -836 | 4,237 | 10,096 | -142 | 30.1 | -56.8 | 32.6 | -187 | -254 |
| Share repurchases | -82.4 | -336 | -145 | -62.7 | -75.9 | -41.9 | -125 | -59.0 | -66.0 | -65.2 | -147 | -342 |
| Debt issued | 0.0 | — | — | 0.0 | 4,295 | 10,034 | — | — | — | — | — | — |
| Debt repaid | -1.4 | -11.1 | -3,451 | -861 | -1.3 | 0.0 | -1.3 | -72.3 | 53.4 | -6.7 | -49.3 | — |
| Effect of exchange rates | -24.2 | -12.7 | 3.4 | -6.8 | 0.5 | 17.9 | -9.7 | 3.3 | 3.0 | -6.9 | 9.3 | -18.0 |
| Net change in cash | 1,194 | 282 | -759 | 362 | -11,591 | 10,466 | -241 | 2,039 | 348 | 390 | -320 | -247 |
| Free cash flow | 746 | 575 | 822 | 605 | 632 | 220 | -108 | 542 | 415 | 438 | -128 | 273 |
| Levered free cash flow | 890 | 778 | 901 | 856 | 1,004 | 335 | -24.0 | 1,280 | 310 | -566 | -224 | 272 |
Financial statements of similar companies
Companies in the group: same industry, similar size
